Regulation of Pancreatic β-Cell Function by the NPY System

Endocrinology. 2021 Aug 1;162(8):bqab070. doi: 10.1210/endocr/bqab070.

Abstract

The neuropeptide Y (NPY) system has been recognized as one of the most critical molecules in the regulation of energy homeostasis and glucose metabolism. Abnormal levels of NPY have been shown to contribute to the development of metabolic disorders including obesity, cardiovascular diseases, and diabetes. NPY centrally promotes feeding and reduces energy expenditure, while the other family members, peptide YY (PYY) and pancreatic polypeptide (PP), mediate satiety. New evidence has uncovered additional functions for these peptides that go beyond energy expenditure and appetite regulation, indicating a more extensive function in controlling other physiological functions. In this review, we will discuss the role of the NPY system in the regulation of pancreatic β-cell function and its therapeutic implications for diabetes.

Keywords: insulin secretion; neuropeptide Y; pancreatic polypeptide; pancreatic β-cell; peptide YY; type 2 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Arginine / analogs & derivatives
  • Arginine / pharmacology
  • Arginine / therapeutic use
  • Diabetes Mellitus / drug therapy
  • Humans
  • Insulin-Secreting Cells / metabolism*
  • Molecular Targeted Therapy
  • Neuropeptide Y / metabolism*
  • Receptors, Neuropeptide Y / antagonists & inhibitors
  • Receptors, Neuropeptide Y / metabolism*

Substances

  • Neuropeptide Y
  • Receptors, Neuropeptide Y
  • Arginine
  • BIBO 3304